A proteasome inhibitor, Boruzu references branded Velcade, a lyophilised powder that needs reconstitution before usage.

Takeda’s Velcade (bortezomib) with pomalidomide and dexamethasone (PVd), after at least one prior line of therapy. GSK teased the result earlier this year, and at ASCO, delegates got a full look ...